Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Dec 10, 2008

Premium
Ronald Lowy has taken over as CEO at Helicos BioSciences for Steve Lombardi, who will stay on in his roles as president of the company and member of the board of directors. Lowy has served on the board since November 2007, a post he will retain. He previously served as president and CEO of Fisher Biosciences, a division of Fisher Scientific, and held management positions at GE Medical Systems.
 
Lombardi will now focus his efforts on commercializing the company’s HeliScope system product line.
 

 
Vermillion has appointed Qun Zhou to serve as interim chief financial officer, a position she has taken over for Richard Taylor, whose consulting agreement with the company expired on Nov. 26. Zhou has been corporate controller at Vermillion since early 2007, and she previously has served in the same position at Vioptix and in various capacities at Philips Medical Systems.

Filed under

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.